Contents:
Document Title
A guideline for management of diabetes in Palliative Care
Document Date
October 2022
Document Purpose and Intended Audience
Guideline to help avoid hypoglycaemia, limit symptomatic hyperglycaemia and avoid unnecessary blood sugar monitoring and complex insulin regimes. This guideline is intended for use by healthcare professionals working with palliative patients.
Authors
Dr Maddy Turley, Palliative Registrar, West Midlands
References
Consultation Process
Reviewed by SPAGG and ratified
Monitoring
This will be audited and reviewed every 3 years
Review Date
(must be within three years)
Dec 2025
Approval Signatures:
SPAGG chair
Dr Jon Tomas
SPAGG secretary
Dr Alice Gray
Date Approved by SPAGG: 13/11/19
Date submitted to Area Prescribing Committee: N/A
Version History
Version 1.1
Date
13/11/2019
Summary of change/ process
Reviewed by SPAGG and ratified
Disclaimer
These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.
Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.
Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.